UPDATED: Safety concerns cloud odanacatib PhIII as Merck steps back from FDA filing Yep, Merck is going to keep raking in those dollars as Oct. layoff looms.
Analysts have it been approved in 2015 for sale in 2016. This $2 billion blockbuster got lowered to $536 million. Source: Reuters.com